Daphna joined Foresite Capital in 2019 and supports the investment team’s research in public and private sectors.
Daphna interned at Foresite the summer before joining full-time. Previously, she interned in financial planning and analysis at Kite Pharma, a cancer cell therapy company that was later acquired by Gilead. Before that, she was a research assistant at a cognitive neuroscience lab in Tel Aviv University, where she helped run experiments and perform a meta-analysis investigating unconscious visual processing. Daphna graduated from the University of Southern California in May 2019 with a Renaissance Scholar distinction, double majoring in Business Administration and Neuroscience.